# HIPOWER

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hipower

- Industry: Biotechnology
- Headquarters: Guangzhou, China
- Website: www.gz-hipower.com
- Latest round: Series B (Oct 14, 2022)
- Investors on record: 6

## About

Established in 2009 and based in Guangzhou, China, HIPOWER is a medical technology company that provides clinical trials of pharmaceutical products. In 2011, the company expanded its service areas cover fields of health food and medical equipment. It is the only CRO company that has passed the international quality management system certification ISO9001:2015 in China. In 2017, the company independently developed EDC data management system and CTMS system, and added clinical research organization (CRO) services. The company has several subsidiaries, including Beijing Haiboxinte Pharmaceutical Research Co., Ltd. and Hangzhou Haitaichuan Biomedical Technology Co., Ltd.

The company’s main business is re-evaluate clinical research and registered clinical trials of medical products. The products cover fields of Chinese medicine, chemical drugs, biological products, diagnostic reagents, healthy food and so on.

## Funding rounds

- Series B, Oct 14, 2022 — Guangzhou Guoju Venture Capital, Tigermed, Wuxi Industrial Jufeng Investment Management, Hanfang Chengji
- Series A, Jan 1, 2017 — Hejun Capital, Guanhao Biotech

## Investors

- Hejun Capital (https://capitalatlas.ai/funds/hejun-capital) — Series A
- Guanhao Biotech — Series A
- Guangzhou Guoju Venture Capital (https://capitalatlas.ai/funds/guangzhou-guoju-venture-capital) — Series B
- Tigermed (https://capitalatlas.ai/funds/tigermed) — Series B
- Wuxi Industrial Jufeng Investment Management (https://capitalatlas.ai/funds/wuxi-industrial-jufeng-investment-management) — Series B
- Hanfang Chengji — Series B